Cargando…
miR-181a is a negative regulator of GRIA2 in methamphetamine-use disorder
A previous study reported that the miR-181a level in serum was significantly different between patients with methamphetamine-use disorder and healthy controls and that chronic methamphetamine use down-regulates the expression of miR-181a. Bioinformatic analysis predicted that miR-181a might bind the...
Autores principales: | Zhang, Kai, Wang, Qingzhong, Jing, Xuxiu, Zhao, Yan, Jiang, Haifeng, Du, Jiang, Yu, Shunying, Zhao, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073328/ https://www.ncbi.nlm.nih.gov/pubmed/27767084 http://dx.doi.org/10.1038/srep35691 |
Ejemplares similares
-
Role of miR-181a-5p in cancer (Review)
por: Li, Junxin, et al.
Publicado: (2023) -
Downregulation of TLR4 by miR-181a Provides Negative Feedback Regulation to Lipopolysaccharide-Induced Inflammation
por: Jiang, Kangfeng, et al.
Publicado: (2018) -
Upregulation of miR181a/miR212 Improves Myogenic Commitment in Murine Fusion-Negative Rhabdomyosarcoma
por: Pozzo, Enrico, et al.
Publicado: (2021) -
A Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons
por: Capauto, Davide, et al.
Publicado: (2018) -
The expression and role of miR-181a in multiple myeloma
por: Yuan, Ruili, et al.
Publicado: (2018)